Latest California Healthline Stories
Dialysis Patients Panic As Financial ‘Life Raft’ Becomes Unmoored
An organization that helps nearly 4,000 California dialysis patients pay for their insurance is threatening to cut off aid in January because of a new law that is expected to reduce dialysis industry profits. Patients fear they won’t be able to afford their life-saving treatment.
Big picture remains hazy, but these numbers add up.
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Bruising Labor Battles Put Kaiser Permanente’s Reputation On The Line
Kaiser Permanente just avoided a nationwide strike by thousands of workers, but now faces a new strike threat Monday. The labor battles are exposing the health care giant to scrutiny from lawmakers, health care advocates and others who accuse it of no longer living up to its nonprofit ideals.
Watch: When Insurance Doesn’t Cover A Mental Health Crisis
CBS This Morning reports on the latest KHN-NPR Bill of the Month.
The Air Ambulance Billed More Than His Surgeon Did For A Lung Transplant
After Tom Saputo underwent double lung transplant surgery in 2018, he was stunned by a surprise bill of more than $11,000 for the 27-mile air ambulance ride to the hospital. State and federal proposals would crack down on extreme air ambulance charges, including a new California law that will limit how much some patients pay for air ambulance rides.
As Congress Works To Curb Surprise Medical Bills, N.Y.’s Fix Gets Examined
A USC-Brookings analysis finds that the New York plan to resolve disputes between providers and insurers without leaving patients on the hook might actually be driving up costs in the system.
As UVA Scales Back Lawsuits, Pain For Past Patients Persists
Patients were thrilled last month when UVA announced it would scale back lawsuits and provide more financial assistance, but the excitement has waned.
FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.